Patents Assigned to Soricimed Biopharma Inc.
  • Compounds and methods for the detection of TRPV-6 cancers and drug delivery
    Patent number: 11090396
    Abstract: Compounds containing TRPV6-binding peptides and their use in the detection and diagnosis of cancer are described. Also described are methods for detecting and staging cancer that use the compounds of the invention. Compounds containing TRPV6-binding peptides are useful for the delivery of diagnostic and therapeutic agents to cells or tumors that express TRPV6.
    Type: Grant
    Filed: July 26, 2018
    Date of Patent: August 17, 2021
    Assignee: Soricimed Biopharma Inc.
    Inventor: John M. Stewart
  • TRPV3 agonists for the treatment of skin conditions
    Patent number: 10864152
    Abstract: Described are methods and uses of TRPV3 agonists for the treatment of conditions associated with TRPV3 pathophysiology such as acne, psoriasis, dermatitis, would healing, the inhibition of hair growth, anxiety or depression. Peptides comprising all or part of the C-terminal portion of soricidin are shown to activate TRPV3 cation channel activity and/or promote wound healing in keratinocytes.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: December 15, 2020
    Assignee: Soricimed Biopharma Inc.
    Inventor: John M. Stewart
  • Compounds and methods for the detection of TRPV-6 cancers and drug delivery
    Patent number: 10064964
    Abstract: Compounds containing TRPV6-binding peptides and their use in the detection and diagnosis of cancer are described. Also described are methods for detecting and staging cancer that use the compounds of the invention. Compounds containing TRPV6-binding peptides are useful for the delivery of diagnostic and therapeutic agents to cells or tumors that express TRPV6.
    Type: Grant
    Filed: December 22, 2014
    Date of Patent: September 4, 2018
    Assignee: SORICIMED BIOPHARMA INC.
    Inventor: John M. Stewart
  • Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity
    Patent number: 10058587
    Abstract: The invention includes an isolated peptide comprising all or part of the amino acid sequence: EGKLSSNDTE GGLCKEFLHP SKVDLPR (SEQ ID NO: 1), wherein the peptide inhibits calcium channel activity. The peptides of the invention are useful for preventing or treating cancer.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: August 28, 2018
    Assignee: Soricimed Biopharma Inc.
    Inventor: John M. Stewart
  • Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity
    Patent number: 9303077
    Abstract: The invention includes an isolated peptide comprising all or part of the amino acid sequence: EGKLSSNDTE GGLCKEFLHP SKVDLPR (SEQ ID NO: 1), wherein the peptide inhibits calcium channel activity. The peptides of the invention are useful for preventing or treating cancer.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: April 5, 2016
    Assignee: Soricimed Biopharma Inc.
    Inventor: John M. Stewart
  • Vectors encoding a paralytic peptide
    Patent number: 8962817
    Abstract: The invention relates to recombinant expression vectors encoding a low molecular weight peptide isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: February 24, 2015
    Assignee: Soricimed Biopharma Inc.
    Inventors: John M Stewart, Bradley J Steeves, Karl Vernes
  • PEPTIDE COMPOSITION FOR CANCER TREATMENT BY INHIBITING TRPV6 CALCIUM CHANNEL ACTIVITY
    Publication number: 20140187493
    Abstract: The invention includes an isolated peptide comprising all or part of the amino acid sequence: EGKLSSNDTE GGLCKEFLHP SKVDLPR (SEQ ID NO: 1), wherein the peptide inhibits calcium channel activity. The peptides of the invention are useful for preventing or treating cancer.
    Type: Application
    Filed: December 23, 2013
    Publication date: July 3, 2014
    Applicant: SORICIMED BIOPHARMA INC.
    Inventor: John M. Stewart
  • Method for treating wrinkles using a paralytic peptide from the shrew
    Patent number: 8673858
    Abstract: The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: March 18, 2014
    Assignee: Soricimed Biopharma Inc.
    Inventors: John M. Stewart, Bradley J. Steeves, Karl Vernes
  • Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity
    Patent number: 8618058
    Abstract: The invention includes an isolated peptide comprising all or part of the amino acid sequence: EGKLSSNDTE GGLCKEFLHP SKVDLPR (SEQ ID NO: 1), wherein the peptide inhibits calcium channel activity. The peptides of the invention are useful for preventing or treating cancer.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: December 31, 2013
    Assignee: Soricimed Biopharma Inc.
    Inventor: John M. Stewart
  • Method of Producing a Paralytic Peptide
    Publication number: 20130165388
    Abstract: The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.
    Type: Application
    Filed: December 21, 2012
    Publication date: June 27, 2013
    Applicant: SORICIMED BIOPHARMA INC.
    Inventor: Soricimed Biopharma Inc.
  • Method of producing a paralytic peptide
    Patent number: 8338136
    Abstract: The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.
    Type: Grant
    Filed: August 1, 2011
    Date of Patent: December 25, 2012
    Assignee: Soricimed Biopharma Inc.
    Inventors: John M. Stewart, Bradley J. Steeves, Karl Vernes
  • Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity
    Patent number: 8211857
    Abstract: The invention includes an isolated peptide comprising all or part of the amino acid sequence: EGKLSSNDTE GGLCKEFLHP SKVDLPR (SEQ ID NO: 1), wherein the peptide inhibits calcium channel activity. The peptides of the invention are useful for preventing or treating cancer.
    Type: Grant
    Filed: September 20, 2010
    Date of Patent: July 3, 2012
    Assignee: Soricimed Biopharma Inc.
    Inventor: John M. Stewart
  • Paralytic Peptide for Use in Neuromuscular Therapy
    Publication number: 20110288030
    Abstract: The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.
    Type: Application
    Filed: August 1, 2011
    Publication date: November 24, 2011
    Applicant: Soricimed Biopharma Inc.
    Inventors: John M. Stewart, Bradley J. Steeves, Karl Vernes
  • Paralytic peptide for use as a insecticide
    Patent number: 8003754
    Abstract: The invention relates to a method of killing or immobilizing an insect comprising administering to the insect a low molecular weight peptide isolated from the submaxiliary saliva glands of shrews of the species Blarina. The invention further relates to an insecticide composition comprising such a peptide.
    Type: Grant
    Filed: June 3, 2010
    Date of Patent: August 23, 2011
    Assignee: Soricimed Biopharma Inc.
    Inventors: John M. Stewart, Bradley J. Steeves, Karl Vernes
  • PEPTIDE COMPOSITION FOR CANCER TREATMENT BY INHIBITING TRPV6 CALCIUM CHANNEL ACTIVITY
    Publication number: 20110071089
    Abstract: The invention includes an isolated peptide comprising all or part of the amino acid sequence: EGKLSSNDTE GGLCKEFLHP SKVDLPR (SEQ ID NO: 1), wherein the peptide inhibits calcium channel activity. The peptides of the invention are useful for preventing or treating cancer.
    Type: Application
    Filed: September 20, 2010
    Publication date: March 24, 2011
    Applicant: SORICIMED BIOPHARMA INC.
    Inventor: John M. Stewart
  • COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY
    Publication number: 20100329983
    Abstract: Compounds containing TRPV6-binding peptides and their use in the detection and diagnosis of cancer are described. Also described are methods for detecting and staging cancer that use the compounds of the invention. Compounds containing TRPV6-binding peptides are useful for the delivery of diagnostic and therapeutic agents to cells or tumors that express TRPV6.
    Type: Application
    Filed: June 28, 2010
    Publication date: December 30, 2010
    Applicant: SORICIMED BIOPHARMA INC.
    Inventor: John M. Stewart